Christy L Osgood

3PUBLICATIONS
30CO-AUTHORS
PharmacogenomicsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Oct 08, 2024
FDA Approval Summary: Capecitabine Labeling Update under Project Renewal.

Sundeep Agrawal, Clara Lee, William F Pierce

|Aug 18, 2023
FDA Approval Summary: Ribociclib Indicated for Male Patients with Hormone Receptor-Positive, HER2-Negative Advanced or Metastatic Breast Cancer.

Jennifer J Gao, Christy L Osgood, Zhou Feng

|Aug 04, 2022
FDA Approval Summary: Pembrolizumab for Neoadjuvant and Adjuvant Treatment of Patients with High-Risk Early-Stage Triple-Negative Breast Cancer.

Mirat Shah, Christy L Osgood, Anup K Amatya

Pageof 1

Frequent Collaborators

3 joint publications

William F Pierce

3 joint publications

Richard Pazdur

3 joint publications

Laleh Amiri-Kordestani

2 joint publications

Paul G Kluetz